Basics AIM ImmunoTech Inc. IPO Date: August 1, 1996 Sector: Healthcare Industry: Biotech Market Cap: $6.52M Activated in VL: False Average Daily Range Avg Daily Range: $0.11 | 3.46% Avg Daily Range (30 D): $0.01 | 6.13% Avg Daily Range (90 D): $0.01 | 5.34% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 413 Avg Trade Size (Sh.) (30 D): 872 Avg Trade Size (Sh.) (90 D): 971 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .41M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.79M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 312.22K         News Apr 4, 2025 @ 8:45 PM AIM ImmunoTech Announces NYSE American Notice of D... Source: Aim Immunotech Inc. Dec 14, 2024 @ 9:54 PM Kellner Group Denounces False Rumors About AIM Sho... Source: N/A Dec 12, 2024 @ 2:00 PM AIM ImmunoTech Expands Patent Portfolio with New N... Source: Aim Immunotech Inc. Sep 27, 2024 @ 12:00 PM AIM ImmunoTech to Participate in Virtual Investor ... Source: Aim Immunotech Inc. Aug 16, 2024 @ 11:00 AM AIM ImmunoTech Reports Second Quarter 2024 Financi... Source: Aim Immunotech Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.31 $-.1 $-.31 Diluted EPS $-.31 $-.1 $-.31 Revenue $ .17M $ .05M $ .17M Gross Profit $ $ $ Net Income / Loss $ -17.32M $ -5.97M $ -17.32M Operating Income / Loss $ -19.77M $ -5.86M $ -19.77M Cost of Revenue $ $ $ Net Cash Flow $ -3.74M $ .79M $ -3.74M PE Ratio